970 related articles for article (PubMed ID: 20397792)
1. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.
Lewis AJ; Galbally M; Opie G; Buist A
Aust N Z J Psychiatry; 2010 May; 44(5):482-7. PubMed ID: 20397792
[TBL] [Abstract][Full Text] [Related]
2. Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study.
Galbally M; Lewis AJ; Lum J; Buist A
Aust N Z J Psychiatry; 2009 Sep; 43(9):846-54. PubMed ID: 19670058
[TBL] [Abstract][Full Text] [Related]
3. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry.
Cardonick E; Usmani A; Ghaffar S
Am J Clin Oncol; 2010 Jun; 33(3):221-8. PubMed ID: 19745695
[TBL] [Abstract][Full Text] [Related]
4. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.
Maschi S; Clavenna A; Campi R; Schiavetti B; Bernat M; Bonati M
BJOG; 2008 Jan; 115(2):283-9. PubMed ID: 17903222
[TBL] [Abstract][Full Text] [Related]
5. Growth in the neonatal period after repeat courses of antenatal corticosteroids: data from the ACTORDS randomised trial.
Battin M; Bevan C; Harding J
Arch Dis Child Fetal Neonatal Ed; 2012 Mar; 97(2):F99-105. PubMed ID: 21798872
[TBL] [Abstract][Full Text] [Related]
6. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
Vega J; Sáez G; Smith M; Agurto M; Morris NM
Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
[TBL] [Abstract][Full Text] [Related]
7. [The effect of cigarette smoking during pregnancy on fetal growth].
Vlajinac H; Petrović R; Marinković J; Kocev N; Sipetić S
Srp Arh Celok Lek; 1997; 125(9-10):267-71. PubMed ID: 9340797
[TBL] [Abstract][Full Text] [Related]
8. No relation between in-utero exposure to HAART and intrauterine growth retardation.
Briand N; Mandelbrot L; Le Chenadec J; Tubiana R; Teglas JP; Faye A; Dollfus C; Rouzioux C; Blanche S; Warszawski J;
AIDS; 2009 Jun; 23(10):1235-43. PubMed ID: 19424054
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects of antidepressant use in pregnancy: an evaluation of fetal growth and preterm birth.
Einarson A; Choi J; Einarson TR; Koren G
Depress Anxiety; 2010; 27(1):35-8. PubMed ID: 19691030
[TBL] [Abstract][Full Text] [Related]
10. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
Riaz M; Porat R; Brodsky NL; Hurt H
J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
[TBL] [Abstract][Full Text] [Related]
11. Depression during pregnancy: rates, risks and consequences--Motherisk Update 2008.
Marcus SM
Can J Clin Pharmacol; 2009; 16(1):e15-22. PubMed ID: 19164843
[TBL] [Abstract][Full Text] [Related]
12. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth.
Suri R; Altshuler L; Hellemann G; Burt VK; Aquino A; Mintz J
Am J Psychiatry; 2007 Aug; 164(8):1206-13. PubMed ID: 17671283
[TBL] [Abstract][Full Text] [Related]
13. Maternal fish consumption, fetal growth and the risks of neonatal complications: the Generation R Study.
Heppe DH; Steegers EA; Timmermans S; Breeijen Hd; Tiemeier H; Hofman A; Jaddoe VW
Br J Nutr; 2011 Mar; 105(6):938-49. PubMed ID: 21266095
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect on prematurity, birth weight, and infant growth from exposure to protease inhibitors in utero and after birth.
Carceller A; Ferreira E; Alloul S; Lapointe N
Pharmacotherapy; 2009 Nov; 29(11):1289-96. PubMed ID: 19857146
[TBL] [Abstract][Full Text] [Related]
15. Antenatal betamethasone and fetal growth in prematurely born children: implications for temperament traits at the age of 2 years.
Pesonen AK; Räikkönen K; Lano A; Peltoniemi O; Hallman M; Kari MA
Pediatrics; 2009 Jan; 123(1):e31-7. PubMed ID: 19074961
[TBL] [Abstract][Full Text] [Related]
16. New and improved Israeli reference of birth weight, birth length, and head circumference by gestational age: a hospital-based study.
Davidson S; Sokolover N; Erlich A; Litwin A; Linder N; Sirota L
Isr Med Assoc J; 2008 Feb; 10(2):130-4. PubMed ID: 18432026
[TBL] [Abstract][Full Text] [Related]
17. Maternal age, parity and gestational age on the size of the newborn in Addis Ababa.
Feleke Y; Enquoselassie F
East Afr Med J; 1999 Aug; 76(8):468-71. PubMed ID: 10520356
[TBL] [Abstract][Full Text] [Related]
18. Developmental outcomes of children exposed to antidepressants in pregnancy.
Galbally M; Lewis AJ; Buist A
Aust N Z J Psychiatry; 2011 May; 45(5):393-9. PubMed ID: 21314237
[TBL] [Abstract][Full Text] [Related]
19. Antenatal phenobarbital therapy and neonatal outcome. II: Neurodevelopmental outcome at 36 months.
Shankaran S; Woldt E; Nelson J; Bedard M; Delaney-Black V
Pediatrics; 1996 May; 97(5):649-52. PubMed ID: 8628601
[TBL] [Abstract][Full Text] [Related]
20. Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age.
Pedersen LH; Henriksen TB; Olsen J
Pediatrics; 2010 Mar; 125(3):e600-8. PubMed ID: 20176667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
